TCR αβ+/CD19+ cell depletion in haploidentical hematopoietic allogeneic stem cell transplantation: a review of current data.


Journal

Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 7 9 2018
medline: 1 5 2020
entrez: 7 9 2018
Statut: ppublish

Résumé

Allogeneic hematopoietic stem cell transplantation is a curative option for patients with a variety of diseases. Transplantation from a related haploidentical donor is being increasingly utilized for patients who lack an available human leukocyte antigen matched related or unrelated donor. One of the strategies used for haploidentical transplants involves selective depletion of T cells expressing the αβ T cell receptor and CD19+ B cells prior to transplant. This allows for the removal of cells responsible for graft-versus-host disease and post-transplant lymphoproliferative disorder but maintains hematopoietic progenitor and stem cells for engraftment (CD34+ cells), as well as cells to elicit graft-versus-tumor effect and provide anti-infective activity (such as gamma-delta T cells and natural killer cells). The aim of this review article is to present and discuss the data available to date from studies utilizing this method of transplantation.

Identifiants

pubmed: 30187806
doi: 10.1080/10428194.2018.1485905
pmc: PMC6764418
mid: NIHMS1051506
doi:

Substances chimiques

Antigens, CD19 0
Receptors, Antigen, T-Cell, alpha-beta 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

598-609

Subventions

Organisme : NCI NIH HHS
ID : P30 CA014520
Pays : United States

Références

Transplantation. 2008 Feb 15;85(3):386-90
pubmed: 18322430
J Hematother. 1999 Apr;8(2):209-18
pubmed: 10349915
Blood. 2007 Jul 1;110(1):433-40
pubmed: 17371948
J Immunother. 2005 Jan-Feb;28(1):73-8
pubmed: 15614047
Cytotherapy. 2007;9(8):746-54
pubmed: 17917892
N Engl J Med. 1998 Oct 22;339(17):1186-93
pubmed: 9780338
Science. 2002 Mar 15;295(5562):2097-100
pubmed: 11896281
Hematology. 2017 Apr;22(3):136-144
pubmed: 27724812
Blood. 1999 Jul 1;94(1):333-9
pubmed: 10381530
Bone Marrow Transplant. 1998 May;21(10):987-93
pubmed: 9632271
J Clin Invest. 2003 Dec;112(12):1862-70
pubmed: 14679181
J Immunol. 2004 Jan 1;172(1):644-50
pubmed: 14688377
Blood. 2009 Mar 26;113(13):3119-29
pubmed: 18945967
Ann N Y Acad Sci. 2007 Jun;1106:279-89
pubmed: 17442774
Br J Haematol. 2009 Jun;145(6):816-24
pubmed: 19344418
Exp Hematol. 1999 May;27(5):860-7
pubmed: 10340402
J Hematother. 1996 Oct;5(5):503-9
pubmed: 8938522
Bone Marrow Transplant. 2016 May;51(5):668-74
pubmed: 26808573
Blood. 2017 Aug 3;130(5):677-685
pubmed: 28588018
Bone Marrow Transplant. 2007 Jun;39(12):751-7
pubmed: 17450185
Cytotherapy. 2013 Oct;15(10):1253-8
pubmed: 23993299
Blood. 2006 Feb 1;107(3):1230-2
pubmed: 16239436
Blood. 2015 Apr 9;125(15):2349-58
pubmed: 25612623
Blood. 2014 Jul 31;124(5):822-6
pubmed: 24869942
Biol Blood Marrow Transplant. 2005 Mar;11(3):161-8
pubmed: 15744234
Transplantation. 2001 Dec 27;72(12):1907-14
pubmed: 11773887
N Engl J Med. 2014 Jul 24;371(4):339-48
pubmed: 25054717
Biol Blood Marrow Transplant. 2016 Nov;22(11):2056-2064
pubmed: 27519279
Biol Blood Marrow Transplant. 2017 Mar;23(3):483-490
pubmed: 28039080
Oncoimmunology. 2016 Sep 27;6(2):e1216291
pubmed: 28344861
J Clin Oncol. 2005 May 20;23(15):3447-54
pubmed: 15753458
Blood. 2012 Jun 21;119(25):6145-54
pubmed: 22563089
Bone Marrow Transplant. 2015 Jun;50 Suppl 2:S6-10
pubmed: 26039210
Blood Cells Mol Dis. 2008 Jan-Feb;40(1):13-9
pubmed: 17869547
Curr Opin Hematol. 2017 Nov;24(6):489-495
pubmed: 28817402

Auteurs

Kieran Sahasrabudhe (K)

a Department of Medicine , School of Medicine and Public Health, University of Wisconsin , Madison , WI , USA.

Mario Otto (M)

b Division of Pediatric Hematology Oncology, and Bone Marrow Transplant, Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin , Madison , WI , USA.
c University of Wisconsin Carbone Cancer Center , Madison , WI , USA.

Peiman Hematti (P)

a Department of Medicine , School of Medicine and Public Health, University of Wisconsin , Madison , WI , USA.
c University of Wisconsin Carbone Cancer Center , Madison , WI , USA.

Vaishalee Kenkre (V)

a Department of Medicine , School of Medicine and Public Health, University of Wisconsin , Madison , WI , USA.
c University of Wisconsin Carbone Cancer Center , Madison , WI , USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH